Scoping review of initiation criteria for inhaled nitric oxide in preterm infants (born

Objectives Inhaled nitric oxide (iNO) is a known treatment for pulmonary hypertension (PH) associated with bronchopulmonary dysplasia in preterm infants after 7 days of age (postacute phase). However, a consensus regarding the optimal criteria for initiating iNO therapy in this population in the pos...

Full description

Saved in:
Bibliographic Details
Main Authors: Hidehiko Nakanishi, Shin Kato, Erika Ota, Toshinori Nakashima, Katsuya Hirata, Sota Iwatani, Seiji Yoshimoto, Masayuki Ochiai, Daichi Suzuki, Fumihiko Namba, Yohei Minamitani, Miku Hosokawa, Atsushi Nakao, Takushi Hanita, Arata Oda, Masafumi Miyata
Format: Article
Language:English
Published: BMJ Publishing Group 2024-12-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/14/12/e087740.full
Tags: Add Tag
No Tags, Be the first to tag this record!